Lexicon Pharmaceuticals
LXRX
#6231
Rank
$1.03 B
Marketcap
$2.33
Share price
-0.43%
Change (1 day)
128.43%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -$26.09 Million USD

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are $69.64 Million USD. In 2025 the company made an earning of -$50.35 Million USD, an increase over its 2024 earnings that were of -$0.21 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$26.09 Million-48.17%
2025 -$50.35 Million-74.88%
2024 -$0.21 Billion13.15%
2023 -$0.18 Billion73.74%
2022 -$0.11 Billion16.16%
2021 -$87.76 Million49.82%
2020 -$58.58 Million-147.19%
2019 $0.12 B-203.42%
2018 -$0.13 Billion-15.31%
2017 -$0.15 Billion0.2%
2016 -$0.15 Billion2920.7%
2015 -$4.69 Million-95.33%
2014 -$0.11 Billion-3.61%
2013 -$0.11 Billion-5.52%
2012 -$0.12 Billion-4.17%
2011 -$0.12 Billion15.5%
2010 -$99.58 Million8.36%
2009 -$91.9 Million-4.81%
2008 -$96.54 Million28.79%
2007 -$74.96 Million35.71%
2006 -$55.24 Million52.91%
2005 -$36.12 Million-23.89%
2004 -$47.46 Million-24.19%
2003 -$62.6 Million-0.48%
2002 -$62.9 Million44.12%
2001 -$43.64 Million23.01%
2000 -$35.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
$7.42 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$1.16 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$5.15 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-$0.54 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.19 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$79.38 M-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$23.25 Million-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-$14.92 Million-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA